How to predict proliferative vitreoretinopathy - A prospective study

被引:62
作者
Asaria, RHY
Kon, CH
Bunce, C
Charteris, DG
Wong, D
Luthert, P
Khaw, PT
Aylward, GW
机构
[1] Moorfields Eye Hosp, Dept Vitreoretinal Surg, London EC1V 9EL, England
[2] Moorfields Eye Hosp, Dept Glaucoma, London, England
[3] Inst Ophthalmol, Dept Pathol, Wound Healing Res Unit, London, England
[4] Royal Liverpool Univ Hosp, Vitreoretinal Dept, Liverpool, Merseyside, England
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0161-6420(01)00553-X
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To determine prospectively the accuracy of a predictive risk formula for the development of postoperative proliferative vitreoretinopathy (PVR) when applied in a clinical setting. Design: Prospective noncomparative interventional case series. Participants: Two hundred nineteen subjects undergoing primary vitrectomy for rhegmatogenous retinal detachment were studied. Method: By use of a formula-based discriminant rule, subjects were classified as either high or low risk for the development of PVR, All subjects were followed prospectively. Outcome Measures: Development of postoperative PVR as defined by the updated the Retina Society Classification. Results: Complete data were available on 212 of 219 subjects. There were 130 subjects identified as low risk and 82 subjects as high risk; 9.2% of the low-risk (12 of 130) compared with 28% (23 of 82) of the high-risk subjects had postoperative PVR develop. This difference was statistically significant (P < 0.001). Conclusions: Our study has shown that using a clinical model it is possible to identify subjects at greater risk of PVR developing after primary vitrectomy, Ophthalmology 2001;108:1184-1186 (C) 2001 by the American Academy of Ophthalmology.
引用
收藏
页码:1184 / 1186
页数:3
相关论文
共 15 条
[1]   Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy - Results from a randomized, double-blind, controlled clinical trial [J].
Asaria, RHY ;
Kon, CH ;
Bunce, C ;
Charteris, DG ;
Wong, D ;
Khaw, PT ;
Aylward, GW .
OPHTHALMOLOGY, 2001, 108 (07) :1179-1183
[2]  
BONNET M, 1994, J FR OPHTALMOL, V17, P530
[4]   FAILURE IN RETINAL-DETACHMENT SURGERY [J].
CHIGNELL, AH ;
FISON, LG ;
DAVIES, EWG ;
HARTLEY, RE ;
GUNDRY, MF .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1973, 57 (08) :525-530
[5]   CLINICAL RISK-FACTORS FOR PROLIFERATIVE VITREORETINOPATHY AFTER RETINAL-DETACHMENT SURGERY [J].
GIRARD, P ;
MIMOUN, G ;
KARPOUZAS, J ;
MONTEFIORE, G .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1994, 14 (05) :417-424
[6]   THE CLASSIFICATION OF RETINAL-DETACHMENT WITH PROLIFERATIVE VITREORETINOPATHY [J].
HILTON, G .
OPHTHALMOLOGY, 1983, 90 (02) :121-125
[7]  
KAUFFMANN DJH, 1994, INVEST OPHTH VIS SCI, V35, P900
[8]   Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study [J].
Kon, CH ;
Asaria, RHY ;
Occleston, NL ;
Khaw, PT ;
Aylward, GW .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (05) :506-511
[9]  
KOSNOSKY W, 1994, INVEST OPHTH VIS SCI, V35, P4260
[10]  
LIMB G A, 1991, Eye (London), V5, P686